Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy

被引：41

作者：

Bardet, E

Martin, L

Calais, G

Tuchais, C

Bourhis, J

Rhein, B

Feham, N

Alphonsi, M

机构：

[1] Ctr Reg Luttre Canc Nantes Atlantique, Dept Radiotherapy, F-44805 Nantes, France

[2] Ctr Guillaume Le Conquerant, Le Havre, France

[3] CHU Tours, Tours, France

[4] Ctr Paul Papin, Angers, France

[5] Inst Gustave Roussy, Villejuif, France

[6] CHU, Limoges, France

[7] CHR, Colmar, France

[8] Clin St Catherine, Avignon, France

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37348

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：57 / 60

页数：4

共 14 条

[1] A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer [J].

Anné, PR ;

Curran, WJ .

SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :18-19

[2] New dosing regimens for amifostine: A pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion [J].

Bonner, HS ;

Shaw, LM .

JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02) :166-174

[3] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].

Brizel, DM ;

Wasserman, TH ;

Henke, M ;

Strnad, V ;

Rudat, V ;

Monnier, A ;

Eschwege, F ;

Zhang, J ;

Russell, L ;

Oster, W ;

Sauer, R .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345

[4]

CALABROJONES PM, 1988, CANCER RES, V48, P3634

[5] FINAL REPORT ON PHASE-I TRIAL OF WR-2721 BEFORE PROTRACTED FRACTIONATED RADIATION-THERAPY [J].

KLIGERMAN, MM ;

TURRISI, AT ;

URTASUN, RC ;

NORFLEET, AL ;

PHILLIPS, TL ;

BARKLEY, T ;

RUBIN, P .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (06) :1119-1122

[6] Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study [J].

Koukourakis, MI ;

Kyrias, G ;

Kakolyris, S ;

Kouroussis, C ;

Frangiadaki, C ;

Giatromanolaki, A ;

Retalis, G ;

Georgoulias, V .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2226-2233

[7] PRELIMINARY-RESULTS OF A PILOT-STUDY USING WR-2721 BEFORE FRACTIONATED-IRRADIATION OF THE HEAD AND NECK TO REDUCE SALIVARY-GLAND DYSFUNCTION [J].

MCDONALD, S ;

MEYEROWITZ, C ;

SMUDZIN, T ;

RUBIN, P .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (04) :747-754

[8] COMPARATIVE BIODISTRIBUTION AND RADIOPROTECTION STUDIES WITH 3 RADIOPROTECTIVE DRUGS IN MOUSE-TUMORS [J].

RASEY, JS ;

KROHN, KA ;

MENARD, TW ;

SPENCE, AM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1487-1490

[9]

Schönekäs KG, 1999, STRAHLENTHER ONKOL, V175, P27

[10] HUMAN PHARMACOKINETICS OF WR-2721 [J].

SHAW, LM ;

TURRISI, AT ;

GLOVER, DJ ;

BONNER, HS ;

NORFLEET, AL ;

WEILER, C ;

KLIGERMAN, MM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1501-1504

← 1 2 →